Pharmacodynamicstudies in a neuroblastoma xenograft mouse modelconfirmed that both SK4454 and SK5527 efficiently degraded AURKA invivo following a single intravenous dose of 15 mg/kg. This evidence concerns the gene AURKA and neuroblastoma.